Secondary hyperparathyroidism is a common complication among patients undergoing maintenance hemodialysis.Approximately 60％of patients with chronic kidney disease exhibit varying degrees of secondary hyperparathyroidism.The control rate of intact parathyroid hormone in these patients remains at approximately 55％.The clinical manifestations of secondary hyperparathyroidism primarily consist of elevated parathyroid hormone levels and persistent calcium and phosphorus metabolism disorders,which can lead to skin,bone,and cardiovascular and cerebrovascular diseases.These conditions significantly affect patients'quality of life and may even lead to increased mortality rates.This article aims to review the progress in the treatment of secondary hyperparathyroidism based on the latest relevant research.
NETL
NSTL
万方数据
